Cargando…

Main Targets of Interest for the Development of a Prophylactic or Therapeutic Epstein-Barr Virus Vaccine

Epstein-Barr virus (EBV) is one of the most widespread viruses in the world; more than 90% of the planet’s adult population is infected. Symptomatic primary infection by this Herpesviridae corresponds to infectious mononucleosis (IM), which is generally a benign disease. While virus persistence is o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jean-Pierre, Vincent, Lupo, Julien, Buisson, Marlyse, Morand, Patrice, Germi, Raphaële
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Microbiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8258399/ https://www.ncbi.nlm.nih.gov/pubmed/34239514 http://dx.doi.org/10.3389/fmicb.2021.701611

Ejemplares similares

Lytic EBV infection investigated by detection of Soluble Epstein-Barr virus ZEBRA in the serum of patients with PTLD
por: Habib, Mohammed, et al.
Publicado: (2017)

Virological Markers in Epstein–Barr Virus-Associated Diseases
por: Lupo, Julien, et al.
Publicado: (2023)

Comparison of Elecsys and Liaison immunoassays to determine Epstein–Barr virus serological status using further diagnostic approaches to clarify discrepant results
por: Lupo, Julien, et al.
Publicado: (2022)

High Predictive Value of the Soluble ZEBRA Antigen (Epstein-Barr Virus Trans-Activator Zta) in Transplant Patients with PTLD
por: Lupo, Julien, et al.
Publicado: (2022)

Urgency and necessity of Epstein-Barr virus prophylactic vaccines
por: Zhong, Ling, et al.
Publicado: (2022)

Evaluation of six commercial SARS-CoV-2 rapid antigen tests in nasopharyngeal swabs: Better knowledge for better patient management?
por: Andreani, Julien, et al.
Publicado: (2021)

Fatal case of acute gastroenteritis with multiple viral coinfections()
por: Lupo, Julien, et al.
Publicado: (2016)

The Status and Prospects of Epstein–Barr Virus Prophylactic Vaccine Development
por: Sun, Cong, et al.
Publicado: (2021)

Sustained virological and biochemical responses to lamivudine and adefovir dipivoxil combination in a chronic hepatitis B infection despite mutations conferring resistance to both drugs
por: Larrat, Sylvie, et al.
Publicado: (2008)

Difference in cytokine production and cell cycle progression induced by Epstein-Barr virus Lmp1 deletion variants in Kmh2, a Hodgkin lymphoma cell line
por: Sueur, Charlotte, et al.
Publicado: (2014)

Evolution of EBV seroprevalence and primary infection age in a French hospital and a city laboratory network, 2000–2016
por: Fourcade, Grégoire, et al.
Publicado: (2017)

The role of Epstein–Barr virus in nasopharyngeal carcinoma
por: Su, Zhi Yi, et al.
Publicado: (2023)

Epstein–Barr Virus, the Immune System, and Associated Diseases
por: Chen, Mei-Ru
Publicado: (2011)

Epstein–Barr Virus: Diseases Linked to Infection and Transformation
por: Jha, Hem C., et al.
Publicado: (2016)

Molecular signature of Epstein Barr virus-positive Burkitt lymphoma and post-transplant lymphoproliferative disorder suggest different roles for Epstein Barr virus
por: Navari, Mohsen, et al.
Publicado: (2014)

Persistence at one year of neutralizing antibodies after SARS-CoV-2 infection: Influence of initial severity and steroid use
por: Epaulard, Olivier, et al.
Publicado: (2022)

Epstein–Barr virus vaccines
por: Cohen, Jeffrey I
Publicado: (2015)

Epstein–barr virus vaccines
por: Cohen, Jeffrey I
Publicado: (2015)

Immune Escape by Non-coding RNAs of the Epstein Barr Virus
por: Münz, Christian
Publicado: (2021)

Novel Therapeutics for Epstein–Barr Virus
por: Andrei, Graciela, et al.
Publicado: (2019)

Declining Epstein-Barr Virus Antibody Prevalence in College Freshmen Strengthens the Rationale for a Prophylactic EBV Vaccine
por: Balfour, Henry H., et al.
Publicado: (2022)

Structural basis of DNA methylation-dependent site selectivity of the Epstein–Barr virus lytic switch protein ZEBRA/Zta/BZLF1
por: Bernaudat, Florent, et al.
Publicado: (2021)

Vaccination against the Epstein–Barr virus
por: Rühl, Julia, et al.
Publicado: (2020)

Perspectives of Phage–Eukaryotic Cell Interactions to Control Epstein–Barr Virus Infections
por: Górski, Andrzej, et al.
Publicado: (2018)

Epstein–Barr Virus-Induced Metabolic Rearrangements in Human B-Cell Lymphomas
por: Piccaluga, Pier P., et al.
Publicado: (2018)

Epstein-Barr Virus Limits the Accumulation of IPO7, an Essential Gene Product
por: Yang, Ya-Chun, et al.
Publicado: (2021)

Subcellular Localization of Epstein–Barr Virus BLLF2 and Its Underlying Mechanisms
por: Li, Jingjing, et al.
Publicado: (2021)

Deletion of Viral microRNAs in the Oncogenesis of Epstein–Barr Virus-Associated Lymphoma
por: Kimura, Hiroshi, et al.
Publicado: (2021)

Plasma Exosomal Proteomic Pattern of Epstein-Barr Virus-Associated Hemophagocytic Lymphohistiocytosis
por: Xie, Yan, et al.
Publicado: (2022)

Early T Cell Recognition of B Cells following Epstein-Barr Virus Infection: Identifying Potential Targets for Prophylactic Vaccination
por: Brooks, Jill M., et al.
Publicado: (2016)

A yeast model for the mechanism of the Epstein-Barr virus immune evasion identifies a new therapeutic target to interfere with the virus stealthiness
por: Lista, María José, et al.
Publicado: (2017)

Epstein–Barr Virus Acquires Its Final Envelope on Intracellular Compartments With Golgi Markers
por: Nanbo, Asuka, et al.
Publicado: (2018)

Corrigendum: Plasma Exosomal Proteomic Pattern of Epstein-Barr Virus-Associated Hemophagocytic Lymphohistiocytosis
por: Xie, Yan, et al.
Publicado: (2022)

Strategies of Epstein-Barr virus to evade innate antiviral immunity of its human host
por: Albanese, Manuel, et al.
Publicado: (2022)

Detection of Human Cytomegalovirus and Epstein-Barr Virus in Coronary Atherosclerotic Tissue
por: Imbronito, Ana Vitória, et al.
Publicado: (2010)

Epstein-Barr virus-driven lymphomagenesis in the context of human immunodeficiency virus type 1 infection
por: Petrara, Maria R., et al.
Publicado: (2013)

The presence of Epstein-Barr virus significantly impacts the transcriptional profile in immunodeficiency-associated Burkitt lymphoma
por: Navari, Mohsen, et al.
Publicado: (2015)

Role of microRNAs and Exosomes in Helicobacter pylori and Epstein-Barr Virus Associated Gastric Cancers
por: Polakovicova, Iva, et al.
Publicado: (2018)

Characterization of a Suppressive Cis-acting Element in the Epstein–Barr Virus LMP1 Promoter
por: Yoshida, Masahiro, et al.
Publicado: (2017)

Modulation of Angiogenic Processes by the Human Gammaherpesviruses, Epstein–Barr Virus and Kaposi’s Sarcoma-Associated Herpesvirus
por: Rivera-Soto, Ricardo, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_mjrnbt69avs7nptg738b82cotb